Trial site
Clinical Research Services Turku -CRST Oy
- 6running trials
- 15closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Mild cognitive impairment4 trials
- Coeliac disease3 trials
- Depression3 trials
- Multiple sclerosis2 trials
- Narcolepsy1 trial
- Parkinson disease1 trial
- Prostate cancer1 trial
- Psoriasis1 trial
- Schizophrenia1 trial
- Phase
- Phase 29 trials
- Phase 37 trials
- Phase 15 trials
- Status
- Completed15 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Glaxosmithkline Research & Development Limited2 trials
- Novo Nordisk A/S2 trials
- Alzinova AB1 trial
- Arctic Bioscience AS1 trial
- Bayer1 trial
- and 14 more
Running trials
Recruiting
Recruiting
Recruiting
A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Coeliac disease1 recruiting
- Multiple sclerosis1 recruiting
- Narcolepsy1 recruiting
Closed trials
Completed
GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.
Completed
Recruiting
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Completed
Completed
Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease
Active, not recruiting
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Completed
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
Completed
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Completed
Active, not recruiting
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: ClinicalTrials.govUpdated 18 Nov 2026